Effects of nicotinamide and carbogen in different murine colon carcinomas: Immunohistochemical analysis of vascular architecture and microenvironmental parameters

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 1, 2004, Pages 310-321

  Van Laarhoven, Hanneke W M ^a   Bussink, Johan ^a   Lok, Jasper ^a   Punt, Cornelis J A ^a   Heerschap, Arend ^a   Van Der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carbogen; Colon carcinoma; Hypoxia; Nicotinamide; Vascular architecture

Indexed keywords

CELL PROLIFERATION; COLON CARCINOMA; NICOTINAMIDE; OXYGENATION;

METABOLISM; MICROSCOPIC EXAMINATION; OXYGENATORS; PATIENT TREATMENT; SENSITIVITY ANALYSIS; TUMORS;

BIOMEDICAL ENGINEERING;

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; BIOLOGICAL MARKER; BROXURIDINE; CARBOGEN; HOE 33342; NICOTINAMIDE; PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON CARCINOMA; COMPUTER; CONTROLLED STUDY; DENSITY; DRUG EFFECT; FROZEN SECTION; HYPOXIA; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OXYGENATION; PERFUSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BENZIMIDAZOLES; BROMODEOXYURIDINE; CARBON DIOXIDE; CELL HYPOXIA; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NIACINAMIDE; NITROIMIDAZOLES; OXYGEN; RADIATION-SENSITIZING AGENTS;

EID: 4444285373     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.05.014     Document Type: Article

References (83)

1. Brown J.M. Exploiting the hypoxic cancer cell Mechanisms and therapeutic strategies. Mol Med Today. 6:2000;157-162
2. Volm M., Koomagi R., Mattern J. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res. 16:1996;213-217
3. Birner P., Schindl M., Obermair A., et al. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors Its impact on prognosis and on response to chemotherapy. Clin Cancer Res. 7:2001;1661-1668
4. Chia S.K., Wykoff C.C., Watson P.H., et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 19:2001;3660-3668
5. Taussky D., Rousson V., Pescia R. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus. Int J Colorect Dis. 18:2003;167-171
6. Nordsmark M., Alsner J., Keller J., et al. Hypoxia in human soft tissue sarcomas Adverse impact on survival and no association with p53 mutations. Br J Cancer. 84:2001;1070-1075
7. Hockel M., Knoop C., Schlenger K., et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 26:1993;45-50
8. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 20:2002;680-687
9. Loncaster J.A., Harris A.L., Davidson S.E., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:2001;6394-6399
10. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 41:1996;31-39
11. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62:2002;7066-7074
12. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys. 53:2002;1192-1202
13. Rockwell S., Kennedy K.A., Sartorelli A.C. Mitomycin-C as a prototype bioreductive alkylating agent In vitro studies of metabolism and cytotoxicity. Int J Radiat Oncol Biol Phys. 8:1982;753-755
14. Zeman E.M., Brown J.M., Lemmon M.J., et al. SR-4233 A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys. 12:1986;1239-1242
15. Trinh Q.T., Austin E.A., Murray D.M., et al. Enzyme/prodrug gene therapy Comparison of cytosine deaminase/5- fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res. 55:1995;4808-4812
16. Shibata T., Giaccia A.J., Brown J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7:2000;493-498
17. Churchill-Davidson L., Sanger C., Thomlinson R.H. High pressure oxygen and radiotherapy. Lancet. 1:1955;1091
18. Haffty B.G., Hurley R.A., Peters L.G. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen Long-term tumor control and complications. Int J Radiat Oncol Biol Phys. 45:1999;13-20
19. Falk S.J., Ward R., Bleehen N.M. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. Br J Cancer. 66:1992;919-924
20. Kaanders J.H., Bussink J., van der Kogel A.J. ARCON A novel biology-based approach in radiotherapy. Lancet Oncol. 3:2002;728-737
21. Kaanders J.H., Pop L.A., Marres H.A., et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol. 48:1998;115-122
22. Hoskin P.J., Saunders M.I., Phillips H., et al. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer. 76:1997;260-263
23. Droller M.J. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide. J Urol. 163:2000;1600
24. Pigott K., Dische S., Saunders M.I. Short communication The addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer. Br J Radiol. 68:1995;215-218
25. Bernier J., Denekamp J., Rojas A., et al. ARCON Accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: A phase I/II study by the EORTC. Radiother Oncol. 52:1999;149-156
26. Miralbell R., Mornex F., Greiner R., et al. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme Report of European Organization for Research and Treatment of Cancer trial 22933. J Clin Oncol. 17:1999;3143-3149
27. Fatigante L., Ducci F., Cartei F., et al. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme A new modality treatment. Int J Radiat Oncol Biol Phys. 37:1997;499-504
28. Powell M.E., Hill S.A., Saunders M.I., et al. Effect of carbogen breathing on tumour microregional blood flow in humans. Radiother Oncol. 41:1996;225-231
29. van der Sanden B.P., Heerschap A., Hoofd L., et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med. 42:1999;490-499
30. Dunn T.J., Braun R.D., Rhemus W.E., et al. The effects of hyperoxic and hypercarbic gases on tumour blood flow. Br J Cancer. 80:1999;117-126
31. Lanzen J.L., Braun R.D., Ong A.L., et al. Variability in blood flow and pO2 in tumors in response to carbogen breathing. Int J Radiat Oncol Biol Phys. 42:1998;855-859
32. Brown D.M., Evans J.W., Brown J.M. The influence of inhibitors of poly (ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair. Br J Cancer. 6:(Suppl.):1984;27-31
33. Chaplin D.J., Horsman M.R., Trotter M.J. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst. 82:1990;672-676
34. Lee I., Boucher Y., Jain R.K. Nicotinamide can lower tumor interstitial fluid pressure Mechanistic and therapeutic implications. Cancer Res. 52:1992;3237-3240
35. Peters C.E., Chaplin D.J., Hirst D.G. Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent manner. Br J Radiol. 70:1997;160-167
36. Honess D.J., Kitamoto Y., Rampling M.R., et al. Nicotinamide and pentoxifylline increase human leucocyte filterability A possible mechanism for reduction of acute hypoxia. Br J Cancer. 27:(Suppl.):1996;236-240
37. Hulshof M.C., Rehmann C.J., Booij J., et al. Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma A 99mTc-HMPAO SPECT study. Radiother Oncol. 48:1998;135-142
38. Honess D.J., Bleehen N.M. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined. Br J Cancer. 71:1995;1175-1180
39. Kelleher D.K., Vaupel P.W. Possible mechanisms involved in tumor radiosensitization following nicotinamide administration. Radiother Oncol. 32:1994;47-53
40. Robinson S.P., Howe F.A., Stubbs M., et al. Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels. Br J Cancer. 82:2000;2007-2014
41. Farouk R., Nelson H., Gunderson L.L. Aggressive multimodality treatment for locally advanced irresectable rectal cancer. Br J Surg. 84:1997;741-749
42. Simmonds P.C. Palliative chemotherapy for advanced colorectal cancer Systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ. 321:2000;531-535
43. Van Laar J.A.M., Rustum Y.M., Van der Wilt C.L., et al. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas. Cancer Chemother Pharmacol. 39:1996;79-89
44. Raleigh J.A., Franko A.J., Treiber E.O., et al. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice Detection by F-19 nuclear magnetic resonance at 2.35 T. Int J Radiat Oncol Biol Phys. 12:1986;1243-1245
45. Raleigh J.A., Miller G.G., Franko A.J., et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer. 56:1987;395-400
46. Durand R.E., Raleigh J.A. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res. 58:1998;3547-3550
47. Arteel G.E., Thurman R.G., Yates J.M., et al. Evidence that hypoxia markers detect oxygen gradients in liver Pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 72:1995;889-895
48. Raleigh J.A., Chou S.C., Arteel G.E., et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 151:1999;580-589
49. Ljungkvist A.S., Bussink J., Rijken P.F., et al. Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys. 48:2000;1529-1538
50. Cline J.M., Thrall D.E., Page R.L., et al. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br J Cancer. 62:1990;925-931
51. Westphal J.R., van't Hullenaar R.G., van der Laak J.A., et al. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer. 76:1997;561-570
52. Azuma C., Raleigh J.A., Thrall D.E. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat Res. 148:1997;35-42
53. Rijken P.F., Bernsen H.J., van der Kogel A.J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res. 50:1995;141-153
54. Bussink J., Kaanders J.H., Rijken P.F., et al. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer. 77:1998;57-64
55. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 9:1955;539-549
56. Brown J.M. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 52:1979;650-656
57. Vaupel P., Schlenger K., Knoop C., et al. Oxygenation of human tumors Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51:1991;3316-3322
58. Fenton B.M., Paoni S.F., Lee J., et al. Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements. Br J Cancer. 79:1999;464-471
59. Airley R.E., Loncaster J., Raleigh J.A., et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix Relationship to pimonidazole binding. Int J Cancer. 104:2003;85-91
60. Bussink J., Kaanders J.H., Rijken P.F., et al. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts Effects of carbogen and nicotinamide. Radiother Oncol. 50:1999;173-184
61. Bussink J., Kaanders J.H., Strik A.M., et al. Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes. Radiother Oncol. 57:2000;21-30
62. Hill S.A., Chaplin D.J. The effect of nicotinamide on microregional blood flow within tumours assessed using laser Doppler probes. Acta Oncol. 34:1995;401-404
63. Crabtree H.G. Observations on the carbohydrate metabolism of tumours. Biochem J. 23:1929;536-545
64. Wojtczak L., Teplova V.V., Bogucka K., et al. Effect of glucose and deoxyglucose on the redistribution of calcium in Ehrlich ascites tumour and Zajdela hepatoma cells and its consequences for mitochondrial energetics. Further arguments for the role of Ca(2+) in the mechanism of the Crabtree effect. Eur J Biochem. 263:1999;495-501
65. Rogers B.J., Chang L., Yanagimachi R. Glucose effect on respiration Possible mechanism for capacitation in guinea pig spermatozoa. J Exp Zool. 207:1979;107-112
66. Guppy M., Greiner E., Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem. 212:1993;95-99
67. Leese H.J., Bronk J.R. Lactate formation by rat small intestine in vitro. Biochim Biophys Acta. 404:1975;40-48
68. Secomb T.W., Hsu R., Ong E.T., et al. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol. 34:1995;313-316
69. Snyder S.A., Lanzen J.L., Braun R.D., et al. Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. Int J Radiat Oncol Biol Phys. 51:2001;494-506
70. Ammon H.P., Estler C.J. The effect of nicotinic acid on glycolytic carbohydrate breakdown in the liver. Life Sci. 6:1967;641-647
71. Moreno F.J., Sanchez-Urrutia L., Medina J.M., et al. Stimulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) activity by low concentrations of circulating glucose in perfused rat liver. Biochem J. 150:1975;51-58
72. Richardson RA, Dewhirst MW. The effect of nicotinamide and hyperoxic gases on blood glucose. In: Wilson D, Evans SM, Birglow J, et al., editors. Oxygen transport to tissue XXIII. New York: Kluwer Academic/Plenum; 2003:375-378
73. Barra R., Randolph V., Sumas M., et al. Effects of nicotinamide, isonicotinamide, and bleomycin on DNA synthesis and repair in rat hepatocytes and hepatoma cells. J Natl Cancer Inst. 69:1982;1353-1357
74. Lea M.A., Barra R., Randolph V., et al. Effects of nicotinamide and structural analogs on DNA synthesis and cellular replication of rat hepatoma cells. Cancer Biochem Biophys. 7:1984;195-202
75. Sjöholm A. Effects of nicotinamide on clonal rat insulinoma cell proliferation, polyamine content and insulin secretion. Anticancer Res. 13:1993;1283-1285
76. Cui Y., An S., Jabr S., et al. The anti-proliferative effects of nicotinamide and 3-aminobenzamide on human smooth muscle cells in vitro. Biochem Mol Biol Int. 31:1993;935-944
77. Pouyssegur J., Franchi A., Pages G. pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found Symp. 240:2001;186-196
78. Van der Sanden B.P., Heerschap A., Hoofd L., et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med. 42:1999;490-499
79. Jirtle R.L. Chemical modification of tumour blood flow. Int J Hyperthermia. 4:1988;355-371
80. Bussink J., Kaanders J.H., Rijken P.F., et al. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts Effects of carbogen and nicotinamide. Radiother Oncol. 50:1999;173-184
81. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49:1989;4373-4384
82. Robinson S.P., Rodrigues L.M., Howe F.A., et al. Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. Magn Reson Imaging. 19:2001;161-166
83. Stubbs M., Robinson S.P., Rodrigues L.M., et al. The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a. Br J Cancer. 78:1998;1449-1456